Seeking Alpha

CNBC reports (video) an unusually high volume of call options in Pharmasset (VRUS +84.7%) were...

CNBC reports (video) an unusually high volume of call options in Pharmasset (VRUS +84.7%) were purchased just a few days before the buyout of the company by Gilead Sciences (GILD -9.7%). Analysts say the activity may get more than a passing glance look from regulators.
Comments (4)
  • HiSpeed
    , contributor
    Comments (1092) | Send Message
     
    Congressional buyers?
    21 Nov 2011, 03:43 PM Reply Like
  • SogoTrade
    , contributor
    Comments (41) | Send Message
     
    The highest open interest as of today was 1154 Dec 80 calls. Doesn't seem that high to me.
    21 Nov 2011, 03:48 PM Reply Like
  • Rick Mortimer
    , contributor
    Comments (3) | Send Message
     
    No unusual volume the last 5 trading days. someone's missing something!
    21 Nov 2011, 03:53 PM Reply Like
  • TraderMark
    , contributor
    Comments (2422) | Send Message
     
    unless they were Congressman
    21 Nov 2011, 03:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|